A New Startup Wants to Edit Human Embryos
PositiveTechnology

Manhattan Genomics, a new biotech startup, is reigniting the conversation around editing human embryos to create disease-free children, seven years after the controversial birth of the first gene-edited babies. This development is significant as it could pave the way for advancements in genetic health, potentially reducing the prevalence of hereditary diseases and improving overall public health.
— Curated by the World Pulse Now AI Editorial System






